Literature DB >> 10999552

Early and late intracortical inhibition in juvenile myoclonic epilepsy.

P Manganotti1, L G Bongiovanni, G Zanette, A Fiaschi.   

Abstract

PURPOSE: We investigated 15 patients with juvenile myoclonic epilepsy (JME) by subjecting them to single and paired transcranial magnetic stimulation to test the hypothesis that motor cortical inhibition may be abnormal in this form of benign epilepsy.
METHODS: Different conditioning paradigms of paired transcranial magnetic stimulation were used with interstimulus intervals (ISIs) of varying lengths (1 to 400 milliseconds) to investigate changes in balance between excitatory and inhibitory intracortical circuits.
RESULTS: Motor evoked potential (MEP) inhibition at ISIs of 1 to 4 milliseconds was significantly lower in JME patients than in age-matched healthy controls (p < 0.001), whereas no significant differences in MEP inhibition were noted at long ISIs (100 to 150 milliseconds). This pattern was observed in both hemispheres in seven of seven patients studied bilaterally and was present in both treated and untreated patients. There were no group differences between JME patients and controls in intracortical facilitation, motor threshold, MEP amplitude, and cortical silent period.
CONCLUSIONS: We documented a different pattern of MEP inhibition in JME patients, suggesting impaired functioning of inhibitory interneuronal circuits, which may account for the hyperexcitability of the motor system in this form of epilepsy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999552     DOI: 10.1111/j.1528-1157.2000.tb00318.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  16 in total

1.  Transcranial Magnetic Stimulation in Epilepsy.

Authors:  William H. Theodore
Journal:  Epilepsy Curr       Date:  2003-11       Impact factor: 7.500

2.  Effects of sleep deprivation on cortical excitability in patients affected by juvenile myoclonic epilepsy: a combined transcranial magnetic stimulation and EEG study.

Authors:  P Manganotti; L G Bongiovanni; G Fuggetta; G Zanette; A Fiaschi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

3.  Cortical hyperexcitability: a new biomarker in generalized epilepsy syndromes.

Authors:  Bernard S Chang
Journal:  Epilepsy Curr       Date:  2013-11       Impact factor: 7.500

Review 4.  Cortical excitability and neurology: insights into the pathophysiology.

Authors:  Radwa A B Badawy; Tobias Loetscher; Richard A L Macdonell; Amy Brodtmann
Journal:  Funct Neurol       Date:  2012 Jul-Sep

5.  Contrast gain control abnormalities in idiopathic generalized epilepsy.

Authors:  Jeffrey J Tsai; Anthony M Norcia; Justin M Ales; Alex R Wade
Journal:  Ann Neurol       Date:  2011-06-27       Impact factor: 10.422

6.  Altered visual contrast gain control is sensitive for idiopathic generalized epilepsies.

Authors:  Daehan Won; Wonsuk Kim; W Art Chaovalitwongse; Jeffrey J Tsai
Journal:  Clin Neurophysiol       Date:  2016-12-18       Impact factor: 3.708

7.  Epileptic baboons have lower numbers of neurons in specific areas of cortex.

Authors:  Nicole A Young; C Ákos Szabó; Clyde F Phelix; David K Flaherty; Pooja Balaram; Kallie B Foust-Yeoman; Christine E Collins; Jon H Kaas
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

8.  Understanding intracortical excitability in phantom limb pain: A multivariate analysis from a multicenter randomized clinical trial.

Authors:  Paulo E P Teixeira; Kevin Pacheco-Barrios; Muhammed Enes Gunduz; Anna Carolyna Gianlorenço; Luis Castelo-Branco; Felipe Fregni
Journal:  Neurophysiol Clin       Date:  2021-02-26       Impact factor: 3.734

Review 9.  Anatomo-Functional Origins of the Cortical Silent Period: Spotlight on the Basal Ganglia.

Authors:  David Zeugin; Silvio Ionta
Journal:  Brain Sci       Date:  2021-05-27

10.  A Systematic Review of Long-Interval Intracortical Inhibition as a Biomarker in Neuropsychiatric Disorders.

Authors:  Parmis Fatih; M Utku Kucuker; Jennifer L Vande Voort; Deniz Doruk Camsari; Faranak Farzan; Paul E Croarkin
Journal:  Front Psychiatry       Date:  2021-06-02       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.